See All Slides - tctmd.com

Slides

Presentation TCT 2014

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Presenter: Alexander Plehn

September 16, 2014

Presentation TCT 2014

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Presenter: Saibal Kar

September 16, 2014

Presentation TCT 2014

Endothelialization of the Multilayer Flow Modulator Versus Single-Layer Arterial Stents

Presenter: Edel Kavanagh

September 16, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Complex Bifurcations: Case #2

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Arif Al Nooryani

September 15, 2014

Presentation TCT 2014

Novel Sheath Technology for TAVR

Presenter: Hemal Gada

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Complex Bifurcations: Case #1

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Yoshinobu Onuma

September 15, 2014

Presentation TCT 2014

New Dedicated Guidewires for TAVR

Presenter: Wesley R. Pedersen

September 15, 2014

Presentation TCT 2014

LpPLA2 Inhibition by Darapladib in Coronary Artery Disease: Game Over or Just Beginning?

Presenter: Ori Ben-Yehuda, Harvey D. White, Roxana Mehran

September 15, 2014

Presentation TCT 2014

Practical Integration: A Modern Cath Lab-Based Imaging Service (and Lessons Learned)

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Ning Guo

September 15, 2014

Presentation TCT 2014

Bioresorbable Scaffold Use in Bifurcations: Insights from OCT

Presenter: David Hildick-Smith, Paul S. Teirstein, Azeem Latib, Jens Flensted Lassen

September 15, 2014

Advertisement

Slides

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Endothelialization of the Multilayer Flow Modulator Versus Single-Layer Arterial Stents

Bioresorbable Scaffold Use in Complex Bifurcations: Case #2

Novel Sheath Technology for TAVR

Bioresorbable Scaffold Use in Complex Bifurcations: Case #1

New Dedicated Guidewires for TAVR

LpPLA2 Inhibition by Darapladib in Coronary Artery Disease: Game Over or Just Beginning?

Practical Integration: A Modern Cath Lab-Based Imaging Service (and Lessons Learned)

Bioresorbable Scaffold Use in Bifurcations: Insights from OCT

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content